Registered Trials
-
NCT04973449
Phase 2/3Brazil, United Kingdom of Great Britain and Northern Ireland
Total Enrollment: 2,475
Official Trial Registration:
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.